Dr. Fraud’s jungle, where science is the prey

With the advent of Open Access – a new publishing model that asks researchers to pay to make their research publicly accessible – unscrupulous predators were granted easy access to a house full of naïve and ingenuous scientists and doctors, and today thrive at their expense, and at the expense of science, including cancer research. [more]

Cancer clinical trials recruit younger and younger patients

15 July 2019 0

Seminal data from decades ago already demonstrated a marked underrepresentation of older patients in clinical trials: now an analysis of more than 300 randomised clinical trials (RCTs) shows not only that the disparity persists but the gap between trial and population median ages is widening. [more]

Why the Cancer World Journalism Award is more important than ever

15 July 2019 0

What’s the real story? This month Cancer World launches its latest Journalism Award, and it’s more important than it’s ever been. A year ago, the overall winner of the last award explained why it meant so much to her.

“I am glad that the voices of the poorest Indian cancer patients are heard across the world and I hope there is an improvement in their access to treatment,” said Swagata [more]